Is it sufficient to evaluate COVID-19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?
作者信息
Yildirim Fatma, Yildirim Mehmet
机构信息
Department of Pulmonary Diseases, COVID Intensive Care Unit, University of Health Sciences, Diskapi Yildirim Beyazit Research and Education Hospital, Ankara, Turkey.
Department of Internal Medicine, COVID Intensive Care Unit, University of Health Sciences, Diskapi Yildirim Beyazit Research and Education Hospital, Ankara, Turkey.
出版信息
Clin Respir J. 2022 Jul;16(7):533-534. doi: 10.1111/crj.13520. Epub 2022 Jul 5.
Abstract
摘要
相似文献
1
Is it sufficient to evaluate COVID-19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?仅根据静脉血栓栓塞症（VTE）风险因素来评估新冠病毒感染的重症患者是否足够？疾病严重程度又如何考量呢？
Clin Respir J. 2022 Jul;16(7):533-534. doi: 10.1111/crj.13520. Epub 2022 Jul 5.
2
Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients.
Chest. 2023 Jul;164(1):215-218. doi: 10.1016/j.chest.2023.02.008. Epub 2023 Feb 12.
3
New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19-A Large Postmortem and Clinical Analysis.新型冠状病毒肺炎危重症患者静脉血栓栓塞症发生的新认识——一项大型尸检及临床分析
Viruses. 2022 Apr 14;14(4):811. doi: 10.3390/v14040811.
4
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。
Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.
5
Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.静脉血栓栓塞并非危重症COVID-19患者发生血流感染的危险因素。
Thromb Res. 2021 Oct;206:128-130. doi: 10.1016/j.thromres.2021.08.019. Epub 2021 Aug 25.
6
The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.严重急性呼吸综合征冠状病毒 2 感染的危重病患者与严重流感和社区获得性肺炎患者的静脉血栓栓塞发生率：一项回顾性图表回顾。
Med Sci (Basel). 2022 Jun 8;10(2):30. doi: 10.3390/medsci10020030.
7
Venous Thromboembolism among Critically Ill Children: A Narrative Review.危重症儿童静脉血栓栓塞症：一项叙述性综述。
Semin Thromb Hemost. 2021 Sep;47(6):631-642. doi: 10.1055/s-0041-1722847. Epub 2021 May 31.
8
COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.危重症患者感染新型冠状病毒肺炎后发生静脉血栓栓塞的风险很高。
Eur J Vasc Endovasc Surg. 2021 Apr;61(4):628-634. doi: 10.1016/j.ejvs.2020.12.015. Epub 2020 Dec 23.
9
The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients.COVID-19 重症患者与非 COVID 重症患者相比，静脉血栓栓塞症的发生率。
Ir J Med Sci. 2021 Nov;190(4):1317-1320. doi: 10.1007/s11845-020-02503-0. Epub 2021 Jan 7.
10
Venous thromboembolism prophylaxis in critically ill patients.危重症患者的静脉血栓栓塞预防。
Crit Care Clin. 2011 Oct;27(4):765-80, v. doi: 10.1016/j.ccc.2011.07.001. Epub 2011 Sep 13.
引用本文的文献
1
Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview.脓毒症弥散性血管内凝血的病理生理学：临床重点概述。
Cells. 2023 Aug 22;12(17):2120. doi: 10.3390/cells12172120.
本文引用的文献
1
Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.新型冠状病毒肺炎患者静脉血栓栓塞症与出血的风险评估。
Clin Respir J. 2022 Mar;16(3):182-189. doi: 10.1111/crj.13467. Epub 2022 Jan 21.
2
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU.新型冠状病毒肺炎相关凝血病：重症监护病房中的血栓栓塞预防及预后不良
Exp Hematol Oncol. 2021 Feb 1;10(1):6. doi: 10.1186/s40164-021-00202-9.
3
DVT incidence and risk factors in critically ill patients with COVID-19.COVID-19 重症患者的 DVT 发生率和危险因素。
J Thromb Thrombolysis. 2021 Jan;51(1):33-39. doi: 10.1007/s11239-020-02181-w.
4
Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?COVID-19 相关静脉血栓栓塞症：目前我们了解多少？
Acta Haematol. 2020;143(5):417-424. doi: 10.1159/000508233. Epub 2020 May 12.
5
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病（COVID-19）严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常：荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.
Zotero 插件